April, 13 2021, 12:00am EDT

On Eve of WTO COVID Meeting: Director General's "Third Way" Is Same Old Way of Big Pharma Control Over COVID Vaccine Supply, Rebranded
The World Trade Organization (WTO) Director General (DG) is holding a "Third Way" COVID-19 vaccine confab in Geneva on April 14th that at best is a distraction from an effective initiative that falls squarely within the WTO's actual remit.
WASHINGTON
The World Trade Organization (WTO) Director General (DG) is holding a "Third Way" COVID-19 vaccine confab in Geneva on April 14th that at best is a distraction from an effective initiative that falls squarely within the WTO's actual remit. That would be a temporary COVID-19 waiver of patent, copyright, industrial design and undisclosed information terms of the WTO Trade Related Aspects of Intellectual Property (TRIPS) agreement, to the extent they hinder the "prevention, treatment and control" of the COVID-19 pandemic.
By design, what the WTO DG has dubbed the "Third Way" is unlikely to help bolster COVID-19 vaccine or treatment supplies because it leaves the same few pharmaceutical firms in total control of supply. Relying on contract manufacturing and voluntary licensing is the approach that has led to massive shortages with a few firms controlling if, where and when supply will be manufactured and can be sold or distributed and at what price. Horrifyingly, the world is not expected to reach herd immunity until 2024 under this regime.
The WTO DG has said that current annual global COVID vaccine production capacity is 3.5 billion doses. But between 10-16 billion are needed to reach herd immunity, assuming 70% of population vaccination levels and some vaccines being two-shot regimes. There is no option but to create significantly more production capacity, especially given the prospect that these will not be one-time shots but perhaps needed on an ongoing basis if, like flu vaccines, they must be repeated or if booster shots have to be given.
The role of the WTO and its DG should be to facilitate negotiations among WTO member nations to fix the problem that is caused by existing WTO rules on intellectual property. Many health and vaccine-specific agencies already have initiatives underway that have failed to coax vaccine originator firms to license or otherwise share their technology. And, not one firm has participated in the World Health Organization's voluntary COVID-19 Technology Access Pool (C-TAP). Various global and even national agencies are better suited than the WTO to play matchmaker between originators and prospective manufacturers.
But missed connections are not the issue: Until policies change so vaccine originating firms do not have total control over production, such as a WTO TRIPS waiver and related government actions to pressure for tech transfers, supplies of vaccines and treatments will remain short. Many qualified firms in developing nations have sought licenses or contract manufacturing deals. Instead of agreeing to boost global production, vaccine originators have used their IP monopolies to effectively block production to supply markets they consider unprofitable. Their focus is not on global access. Consider Pfizer's investor relations VP's recent announcement that the firm will shift production next year to boosters for sale to rich nations at higher prices.
Had the TRIPS waiver of some WTO Trade Related Aspects of Intellectual Property (TRIPS) been agreed when proposed last year, perhaps more than 27% of people in low- and middle- income countries (LMICs) would be projected to get vaccines in 2021. Instead, few will have access until 2022. Many will wait until 2024. The pandemic will rage largely unmitigated among more than three quarters of the world's population.
A temporary TRIPS waiver can make sure "trade" rules are not an obstacle to countries' efforts to protect their residents' health and crush the pandemic. Indeed, the agreement establishing the WTO does not provide authority for the DG to broker deals between private firms. This activity is simply outside of its mandate.
In contrast, negotiating waivers of the obligations contained in WTO agreements due to the development of exceptional circumstances is an explicitly authorized function of the organization. If the COVID-19 pandemic does not constitute such exceptional circumstances, it is unclear what would qualify as such.
Today more than 100 WTO members support the waiver and consider it critical to boost worldwide production of COVID vaccines, treatments and diagnostic tests. Many hoped that the arrival of new WTO DG, economist Ngozi Okonjo-Iweala, might move countries currently blocking the waiver. Because South Africa introduced it and the WTO Africa Group supports it unanimously, some WTO members and activists worldwide hoped that the first African WTO DG could help facilitate progress. However, Okonjo-Iweala did not endorse the waiver. Instead, she diverted attention away from it by suggesting a "third way" that is more of what has failed.
Namely, corporations determine where and how much vaccines and other drugs are produced through highly restrictive voluntary licenses and contract manufacturing arrangements, with the monopoly-holding firms deciding if, how much, where and under what terms chosen partners may produce. One example of what the WTO DG proposes is South African firm Aspen's contract manufacturing arrangement with Johnson & Johnson (J&J). According to South Africa's WTO Counselor, for many months 91% of doses produced in South Africa had to be sent for sale in Europe, while only 9% could be used in South Africa.
Many pharmaceutical industry interests oppose the waiver and have a litany of arguments intended to redirect attention away from the core problem of their monopoly control over supply. They claim developing country firms cannot make these vaccines, even as they make limited contracts for such firms to do so. They claim that IP barriers are not a real obstacle to greater production. If IP was not an obstacle, manufacturers all over the world would already have begun to organize more production to fill the chasm between supply and demand. Instead, there are a limited number of market-segmented contract manufacturing arrangements, as determined by developers who restrict access to the technology. Moderna declined to partner with a qualified Bangladeshi vaccine maker while other firms report never getting any response to their inquiries. Just in Africa, "Biovac and Aspen in South Africa, Institute Pasteur in Senegal, and Vacsera in Egypt could rapidly retool factories to make mRNA vaccines," notes a group of medicine-production experts in a recent Foreign Policy article. Indeed, while COVID-19 shone a spotlight on the mRNA platform, for two decades researchers around the world have attempted to harness it for vaccines and therapies. A former Moderna director of chemistry revealed that with enough technology transfer and knowhow-sharing, a modern factory should be able to get mRNA vaccine production online in three to four months. The result of the originators' unwillingness to partner is a huge gap between needed global supply and the production levels that vaccine developers deem useful for their business strategy, which is focused mostly on selling at higher prices to rich and upper-middle-income countries.
Failure to enact a waiver in the face of this unprecedented health and economic crisis could be the final blow that dooms the WTO. The existential and intensifying crisis that has wracked the WTO in recent years is in no small part a consequence of the organization getting involved in or being used to dealing with issues clearly outside of its mandate. And the WTO's increasing irrelevance is related to the body not succeeding in managing problems and concerns that are directly in its remit.
The "third way" approach would double down on the same mistakes. By not prioritizing the negotiation of waiver language agreeable to all WTO member countries and desperately needed to address THE priority concern of many, the organization will become more irrelevant, while also alienating 100-plus countries that support the TRIPS waiver. If the new DG pulls the WTO -- an organization devised to negotiate and administer rules -- into instead pretending to become an international deal broker, it will only amplify concerns about the WTO staff and structures overstepping the authorities provided by member countries.
The way forward at the WTO is clear. Existing WTO rules are obstacles to scaling up global production and thus facilitating more equitable distribution of affordable, safe and effective COVID-19 vaccines, treatments and tests. Eliminating these obstacles is not the final step to greater production, but the first, so there is no time to waste. The DG's priority should be to pave a quick path to countries engaging in text-based negotiations on a waiver. If some WTO member countries have specific concerns with the waiver that South Africa and India have proposed, then the way forward is to offer changes to that proposal. Facilitating negotiations among WTO members to fix a problem caused by existing WTO rules, by preparing a waiver text that can be approved by all at the WTO General Council, is precisely the role of the DG and the WTO.
Public Citizen is a nonprofit consumer advocacy organization that champions the public interest in the halls of power. We defend democracy, resist corporate power and work to ensure that government works for the people - not for big corporations. Founded in 1971, we now have 500,000 members and supporters throughout the country.
(202) 588-1000LATEST NEWS
GOP Unveils Plan to Give $150 Billion More to Pentagon
"Any additional money pumped into this system is likely to be wasted," said one analyst. "The only beneficiaries will be weapons contractors."
Apr 28, 2025
Congressional Republicans on Sunday released legislation that would pump an additional $150 billion into the Pentagon—a morass of waste and profiteering—over the next decade as part of a sweeping reconciliation package that's also expected to include deep cuts to Medicaid and tax breaks for the wealthy.
The House Armed Services Committee, a major target of weapons industry lobbying, unveiled the plan for what it called "a historic investment of $150 billion to restore America's military capabilities and strengthen our national defense." The panel said the legislation was developed "in close conjunction" with Senate Republicans and President Donald Trump, who is separately pursuing a $1 trillion U.S. military budget for the next fiscal year.
The legislation would direct the new Pentagon funding toward a number of initiatives backed by the president, including a "Golden Dome" missile defense system that experts have called a massive boondoggle that could benefit Elon Musk.
The bill, which is scheduled for a committee markup on Tuesday, also includes $4.5 billion to speed production of the B-21 stealth bomber, a Northrop Grumman-made aircraft capable of delivering nuclear weapons.
William Hartung, a senior research fellow at the Quincy Institute for Responsible Statecraft, said Sunday that the GOP's proposed Pentagon spending increase is "a glaring example of misplaced priorities."
"This is no time to throw more money at a weapons manufacturing base that is already maxed out," said Hartung. "Any additional money pumped into this system is likely to be wasted. The only beneficiaries will be weapons contractors, who will be glad to accept the new funds whether they can use them effectively or not."
"Given that the Pentagon and its contractor network are having a hard time spending existing funds well," Hartung added, "Congress should think twice before sending more taxpayer money their way."
The Republican push for additional Pentagon funding comes as Defense Secretary Pete Hegseth is facing calls to resign for sharing plans for a U.S. military attack on Yemen in at least two private group chats.
Earlier this month, as Common Dreamsreported, Hegseth endorsed Trump's push for a $1 trillion U.S. military budget, which would mark the highest level of spending since the Second World War.
Keep ReadingShow Less
100 Palestinians Killed in Weekend of Israeli Airstrikes on Gaza
Victims include 22 members of one family massacred in their Gaza City home.
Apr 27, 2025
Israel Defense Forces bombing killed at least 100 Palestinians including numerous women and children in the Gaza Strip over the weekend, while the IDF also renewed airstrikes on Lebanon as cease-fire talks between senior Hamas and Egyptian officials wrapped up in Cairo without any breakthrough.
The Gaza Health Ministry said Sunday that Israeli strikes killed at least 51 Palestinians over the previous 24 hours. Among the victims were eight people, including three women and two children, killed in an IDF bombing of a tent in Khan Younis; a man and four children slain in another strike on a tent in Deir al-Balah; and at least six people who died when a coffee shop near the Bureij refugee camp was hit.
The ministry said Saturday that at least 49 Palestinians were killed during the preceding 24 hours, including 22 members of the al-Khour family who were sheltering in their Gaza City home when it was bombed.
The IDF said the strike targeted a Hamas militant. Israel's military relaxed rules of engagement after the October 7, 2023 attack to allow an unlimited number of civilians to be killed when targeting a single Hamas member, no matter how low-ranking.
Saed al-Khour, who is grieving the loss of his family, refuted Israel's claim, tellingThe Associated Press that "there is no one from the resistance" among the victims.
"We have been pulling out the remains of children, women, and elderly people," al-Khour added.
Israel's U.S.-backed 569-day assault on Gaza has left at least 183,800 Palestinians dead, injured, or missing. Nearly all of Gaza's more than 2 million people have been forcibly displaced, starved, or sickened amid a "complete siege" that is cited in an International Court of Justice genocide case against Israel.
Israeli Prime Minister Benjamin Netanyahu and former Defense Minister Yoav Gallant are also fugitives from the International Criminal Court, which issued arrest warrants for the pair last year.
Meanwhile, Israeli forces unleashed a wave of bombing attacks in Lebanon in what critics called a blatant violation of a November cease-fire agreement with the resistance group Hezbollah. The IDF bombed targets in southern Lebanon and in suburbs of the capital city of Beirut.
The IDF, which said it warned residents ahead of the Beirut airstrike, claimed it attacked "an infrastructure where precision missiles" were being stored by Hezbollah, without providing any supporting evidence.
Israel says it will continue its assault and siege on Gaza until Hamas releases the two dozen Israeli and other hostages it has imprisoned since October 2023. Hamas counters that it will only free the hostages in an exchange for Palestinians imprisoned by Israel, a complete withdrawal of IDF troops from Gaza, and a new cease-fire agreement. Israel unilaterally broke a January cease-fire last month.
A senior Hamas delegation left Cairo late Saturday following days of talks regarding a possible deal for a multi-year truce and the release of all remaining hostages. The head of Israel's Mossad spy agency was also in Qatar earlier this week for separate cease-fire talks. Qatari mediators said they believed there has been "some progress" in both sides' willingness to reach an agreement.
United Nations agencies and international humanitarian groups—many of which have accused Israel of using starvation as a weapon of war—have warned in recent days of the imminent risk of renewed famine in Gaza as food stocks run out.
"Children in Gaza are starving," the U.N. Relief and Works Agency for Palestine Refugees in the Near East
said on social media Sunday. "The government of Israel continues to block the entry of food and other basics. [This is a] man-made and politically motivated starvation."
Keep ReadingShow Less
Sanders: 'Oligarchy on Steroids' Poses Existential Threat to Democracy
"If we don't address that issue, the American people will continue to turn their backs on democracy."
Apr 27, 2025
U.S. Sen. Bernie Sanders said Sunday that Democrats lack a "vision for the future," warning that Americans will "turn their backs on democracy" if elected officials fail to tackle an "oligarchy on steroids."
Appearing on NBC News' "Meet the Press," Sanders (I-Vt.) was asked about Sen. Elissa Slotkin's (D-Mich.) recent assertion that Democrats should stop saying "oligarchy" because it only resonates with coastal institutions, and whether he's "missing a chance to speak to a wider audience."
"Well... we had 36,000 people out in Los Angeles, 34,000 people in Colorado, we had 30,000 people in Folsom, California," Sanders replied, referring to the wildly popular Fighting Oligarchy Tour he's currently on with Rep. Alexandria Ocasio-Cortez (D-N.Y.).
"I think the American people are not quite as dumb as Ms. Slotkin thinks they are. I think they understand very well," the senator continued. "When the top 1% owns more wealth than the bottom 90%, when big money interests are able to control both political parties, they are living in an oligarchy."
"And these are precisely the issues that have got to be talked about," Sanders said. "Are you living in a democracy when [Elon] Musk can spend $270 million to elect [President Donald] Trump, and then becomes the most important person in government?"
Sanders called out the American Israel Public Affairs Committee and other super PACs "that have enormous power over Democratic candidates."
"Those are issues that we have got to talk about. That is the reality of American society today. The very rich getting richer, working-class people are struggling, 800,000 people [are] sleeping out on the streets," the democratic socialist contended.
"If we don't address that issue, the American people will continue to turn their backs on democracy, because they're looking around them and they're saying, 'Does anybody understand what I am going through?'" he added. "And unfortunately right now, to a large degree, neither party does."
Sanders urged Democrats to embrace policies like fixing the nation's "broken healthcare system" and raising the minimum wage, pointing to issues on which he is working with colleagues.
"You have Democrats... talking about Trump's movement toward authoritarianism; vigorously opposing the so-called reconciliation bill to give over a trillion dollars in tax breaks for the 1% and make massive cuts to Medicaid, nutrition, and housing; opposing what Musk is doing to dismember the Social Security Administration and the Veterans Administration, making it hard for our veterans to get decent health care or benefits on time," he said.
Sanders argued that the country needs more working-class people to run for office—and not necessarily as Democrats.
"You want to run as a Democrat? Great," he said. "You want to run as an Independent? That's great, but you've got to get involved in the political process, because right now the two-party system is failing the working class of this country."
Keep ReadingShow Less
Most Popular